Simplex Trading’s Sagimet Biosciences SGMT Stock Holding History

Simplex Trading’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$161K	Buy	30,900 +800	+3%	+$4.46K	﹤0.01%	4557
2025 Q4	$178K	Buy	30,100 +13,000	+76%	+$93.4K	﹤0.01%	4346
2025 Q3	$117K	Buy	17,100 +1,300	+8%	+$10.5K	﹤0.01%	5564
2025 Q2	$120K	Buy	15,800 +7,500	+90%	+$31.7K	﹤0.01%	5055
2025 Q1	$27K	Sell	8,300 -22,000	-73%	-$92.3K	﹤0.01%	6340
2024 Q4	$136K	Buy	30,300 +4,400	+17%	+$22.3K	﹤0.01%	4896
2024 Q3	$71K	Sell	25,900 -5,100	-16%	-$15.7K	﹤0.01%	5555
2024 Q2	$106K	Buy	+31,000	New	+$142K	﹤0.01%	5324

Other funds holding SGMT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Simplex Trading's SGMT Position: Q1 2026 in Review

Simplex Trading reduced its Sagimet Biosciences (SGMT) stake by 4.2% in Q1 2026, selling an estimated $3.29K and leaving 13,636 shares worth $71.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5474.

Simplex Trading first reported a position in SGMT in Q2 2024 and has held it in 6 quarters since. The position peaked at $84.2K in Q4 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

Simplex Trading held 13,636 shares of Sagimet Biosciences worth $71.2K as of Q1 2026.
Simplex Trading sold 591 Sagimet Biosciences shares in Q1 2026, an estimated $3.29K.
Sagimet Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5474 holding.
Simplex Trading first reported a position in Sagimet Biosciences in Q2 2024 and has held it in 6 quarters since.
Simplex Trading's Sagimet Biosciences position peaked at $84.2K in Q4 2025.
88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.